Lista de obras - Paul W. Armstrong - Dominio Público Uruguay

1-Year Survival in a Randomized Trial of Facilitated Reperfusion

article by Stephen G. Ellis et al published October 2009 in JACC: Cardiovascular Interventions

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in coll

artículo científico publicado en 2007

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management

artículo científico publicado en 1996

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial

artículo científico publicado en 2017

A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.

artículo científico publicado en 1987

A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications

article

A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study

artículo científico publicado en 2006

A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes

artículo científico publicado en 2006

A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy

artículo científico publicado en 2005

A marriage of enhancement: fibrinolysis and conjunctive therapy

artículo científico publicado en 2004

A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

artículo científico publicado en 2010

A new synthetic approach to 2,3-dideoxy-2-fluoro-β-d-threo-pentofuranose, the fluorofuranose unit of the anti-HIV-active nucleoside, β-FddA

article

A novel enoxaparin regime for ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a WEST sub-study

artículo científico publicado en 2007

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes

artículo científico publicado en 2004

A tale of two countries: Insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes.

artículo científico publicado en 2001

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

article published 3 August 2004 in Circulation

Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

artículo científico publicado en 2012

Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial.

artículo científico publicado en 2014

Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy

artículo científico publicado en 2004

Aborted myocardial infarction: a new target for reperfusion therapy

artículo científico publicado en 2006

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy

artículo científico publicado en 2004

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST–elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy11Guest Editor for this manuscript

article by Stefan K James et al published February 2004 in American Heart Journal

Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial

artículo científico publicado en 2015

Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Ger

artículo científico publicado en 2007

Acute heart failure in the emergency department: Short and long-term outcomes of elderly patients with heart failure

artículo científico publicado en 2008

Acute heart failure: perspectives from a randomized trial and a simultaneous registry

artículo científico

Advancing interdisciplinary health research: a synergism not to be denied

artículo científico publicado en 2006

Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy

artículo científico publicado en 2008

Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.

artículo científico publicado en 2017

Age and Outcomes in ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

article

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

artículo científico publicado en 2006

Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial

artículo científico publicado en 2012

Aggressive clinical pattern of angina at restenosis following coronary angioplasty in unstable angina

scientific article published on 01 November 1992

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

artículo científico publicado en 2016

Aldosterone Antagonists — Last Man Standing? ⬇️

artículo científico publicado el 14 de noviembre de 2010

Alignment of site versus adjudication committee-based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial

artículo científico publicado en 2015

Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure

scientific article published on 01 January 1989

Ameliorating reperfusion injury in STEMI: dead or alive?

artículo científico publicado en 2014

An assessment of ST-segment measurement variability between two core electrocardiogram laboratories

artículo científico publicado en 2013

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

artículo científico publicado en 2004

Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

artículo científico publicado en 2003

Angiographic morphology in unstable angina pectoris

artículo científico publicado en 1988

Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial).

artículo científico publicado en 2014

Anticoagulant therapy in unstable angina.

artículo científico publicado en 1999

Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.

artículo científico publicado en 2012

Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial

artículo científico publicado en 2009

Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial

artículo científico publicado en 2014

Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction

artículo científico publicado en 2004

Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction

artículo científico publicado en 2004

Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis

artículo científico publicado en 2005

Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF).

artículo científico publicado en 2016

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

artículo científico publicado en 2015

Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome

artículo científico publicado en 2015

Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure

artículo científico publicado en 2006

Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation

artículo científico publicado en 2003

Assessing risk in FRISC

artículo científico publicado en 2004

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous corona

artículo científico publicado en 2005

Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow

artículo científico publicado en 2012

Assessment of ventricular function in coronary artery disease by means of atrial pacing and exercise

artículo científico publicado en 1970

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial

artículo científico publicado en 2016

Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial

artículo científico publicado en 2013

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

artículo científico publicado en 2013

Association of global weather changes with acute coronary syndromes: gaining insights from clinical trials data

artículo científico publicado en 2012

Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2014

Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis

artículo científico publicado en 2011

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS

artículo científico publicado en 2004

Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience

article

Balancing the cyclooxygenase portfolio

artículo científico publicado en 2006

Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

artículo científico publicado en 2012

Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sex.

artículo científico publicado en 2015

Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial

artículo científico publicado en 2012

Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

artículo científico publicado en 2009

Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study

artículo científico publicado en 1999

Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial

scientific article published on 09 December 2019

Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals

Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?

artículo científico publicado en 2009

Better Outcomes for Patients Treated at Hospitals That Participate in Clinical Trials

artículo científico publicado en 2008

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

artículo científico publicado en 2017

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.

artículo científico publicado en 2004

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

article

Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.

artículo científico publicado en 1980

Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends

artículo científico

Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".

artículo científico publicado en 2011

Cardiology and emergency medicine: United We Stand, divided we fall

scientific article published on 01 February 2002

Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease

Cardiovascular clinical research in South America

artículo científico

Cardiovascular disease on a global scale: defining the path forward for research and practice

artículo científico publicado en 2007

Cardiovascular drug development: is it dead or just hibernating?

artículo científico

Characterization of hemodynamically stable acute heart failure patients requiring a critical care unit admission: Derivation, validation, and refinement of a risk score

artículo científico publicado en 2017

Charting the course of clinical research: From an inspired past to a promising future

artículo científico publicado en 2004

Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial

artículo científico publicado en 2018

Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).

artículo científico publicado en 2015

Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome

artículo científico publicado en 2013

Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2017

Clinical lessons learned from experimental heart failure

article

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

artículo científico publicado en 2013

Clinical perspectives on reperfusion injury in acute myocardial infarction

artículo científico publicado en 2014

Clopidogrel does not induce fibrinolysis in healthy subjects

artículo científico publicado en 2004

Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS II)

scientific article published on 01 September 2003

Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction

artículo científico publicado en 2004

Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial

artículo científico publicado en 2014

Comparative effects of lidocaine and procainamide on acutely impaired hemodynamics.

artículo científico publicado en 1976

Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome

artículo científico publicado en 2006

Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention

Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis

artículo científico publicado en 2011

Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone

article

Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).

artículo científico publicado en 2008

Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State

artículo científico publicado en 1994

Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.

artículo científico publicado en 2012

Composite End Points in Clinical Research: A Time for Reappraisal

artículo científico

Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction

scientific article published on 01 July 2005

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition

artículo científico publicado en 2015

Contemporary pharmacological reperfusion in ST elevation myocardial infarction

artículo científico

Continuous 12-lead ST-segment recovery predicts outcome in acute myocardial infarction better than “snapshot” angiograms of TIMI flow

Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study Group

artículo científico publicado en 1991

Coronary reperfusion: numerators searching for denominators

scientific article published in The Lancet

Corrections needed to 2016 ESC guideline and AHA scientific statement on heart failure

artículo científico publicado en 2017

Correlation between peak expiratory flow rate and NT-proBNP in patients with acute heart failure. An analysis from ASCEND-HF trial

artículo científico publicado en 2014

Corrigendum to “Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial” [Am Heart J 169/6 (2015) 890–898]

artículo científico publicado en 2017

Cost Effectiveness of Early Discharge after Uncomplicated Acute Myocardial Infarction

article

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

artículo científico publicado en 1995

Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis

artículo científico publicado en 2005

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

artículo científico publicado en 2004

Cycloaddition reactions of oximes; powerful new carbon–carbon bond forming methodology

article

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

article

Data and safety monitoring boards: academic credit where credit is due?

artículo científico publicado en 2013

Death and nonfatal reinfarction within the first 24 hours after presentation with an acute coronary syndrome: Experience from GUSTO-IIb

artículo científico publicado en 1999

Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction

artículo científico publicado en 2009

Defining myocardial infarction: a work in progress: Ischaemic heart disease

artículo científico publicado en 2008

Detection of silent myocardial ischemia in diabetes mellitus

article

Determination of disopyramide and mono-N-desisopropyl-disopyramide in serum by gas-liquid chromatography with nitrogen-selective detection

artículo científico publicado en 1983

Determining the cost economic "tipping point" for the addition of a regional percutaneous coronary intervention facility

artículo científico publicado en 2011

Diabetes and heart failure in the crosshairs: where is the target?

artículo científico publicado en 2017

Diagnosing Acute Myocardial Infarction in Patients With Left Bundle Branch Block

article

Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes

artículo científico publicado en 2007

Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States

artículo científico publicado en 2013

Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome

artículo científico publicado en 2017

Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods

artículo científico publicado en 2004

Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction

artículo científico publicado en 2018

Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

artículo científico publicado en 2010

Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.

artículo científico

Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopri

artículo científico publicado en 2004

Do the investigative sites that take part in a positive clinical trial translate that evidence into practice?

article

Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudy

artículo científico publicado en 2003

Does a hypertonic saline load predict fluid retention in pacing induced heart failure?

artículo científico publicado en 1997

Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina?

artículo científico publicado en 1994

Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes

artículo científico publicado en 2002

Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial

artículo científico publicado en 2002

Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

artículo científico publicado en 2010

Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?

artículo científico publicado en 2003

Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.

artículo científico publicado en 2016

Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.

artículo científico publicado en 2016

Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization

artículo científico publicado en 2017

Dual natriuretic peptide system in experimental heart failure

article

Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.

artículo científico publicado en 2013

Duration of symptoms is the key modulator of the choice of reperfusion for ST-elevation myocardial infarction

artículo científico publicado en 2009

Dynamic modeling of 90-day mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention

artículo científico publicado en 2013

Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT.

artículo científico publicado en 2004

Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis

artículo científico publicado en 2010

Early versus delayed, provisional eptifibatide in acute coronary syndromes

artículo científico publicado en 2009

Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction

artículo científico publicado en 2005

Editorial independence for CMAJ: signposts along the road

artículo científico publicado en 2006

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

artículo científico publicado en 2015

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial

artículo científico publicado en 2020

Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial

artículo científico publicado en 2016

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

artículo científico publicado en 2001

Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: A systematic overview

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

artículo científico publicado en 2003

Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients

artículo científico publicado en 2016

Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial

artículo científico publicado en 2015

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA·CER) trial

artículo científico publicado en 2013

Effects of Socioeconomic Status on Mortality after Acute Myocardial Infarction

artículo científico publicado en 2007

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial

artículo científico publicado en 2018

Effects of hemoperfusion during percutaneous transluminal coronary angioplasty on left ventricular function

artículo científico publicado en 1991

Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

artículo científico publicado en 2006

Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing

artículo científico publicado en 1977

Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.

artículo científico publicado en 2006

Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery

artículo científico publicado en 2015

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomi

artículo científico publicado en 2003

Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)

Efficacy and safety of unfractionated heparin versus enoxaparin: a pooled analysis of ASSENT-3 and -3 PLUS data

artículo científico publicado en 2006

Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction

artículo científico publicado en 2004

Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel

artículo científico

Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women

artículo científico publicado en 2007

Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials

artículo científico publicado en 2006

Elevated left atrial pressure does not cause left-to-right shunting after mitral balloon valvuloplasty

scientific article published on 01 November 1991

Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).

artículo científico publicado en 2010

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial

artículo científico publicado en 2004

Estimating the length of waits: a description of the period lifetable method and comparison with census and event based methods

article

Etiology and differential diagnosis of acute mitral regurgitation

artículo científico publicado en 1971

Evaluating Research in Cardiovascular Medicine

scientific article published on 01 March 2011

Evaluation of Cardiac Magnetic Resonance as a Surrogate in ST-Segment Elevation Myocardial Infarction

artículo científico

Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: contribution of weighting the composite endpoint

artículo científico publicado en 2012

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki

artículo científico publicado en 1995

Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction

artículo científico publicado en 2014

Facilitated PCI in patients with ST-elevation myocardial infarction

artículo científico publicado en 2008

Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial

artículo científico publicado en 2004

Facilitated versus primary PCI for acute myocardial infarction – Authors' reply

artículo científico publicado en 2006

Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI.

artículo científico publicado en 2007

Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center

article

Fibrinolysis for acute myocardial infarction: the future is here and now.

artículo científico publicado en 2003

Fibrinolysis or primary PCI in myocardial infarction

artículo científico publicado en 2013

First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation

artículo científico publicado en 2002

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial

artículo científico publicado en 2005

Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction

artículo científico publicado en 2006

Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial

artículo científico publicado en 2015

Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.

artículo científico publicado en 1999

Frequency of transient reductions in left ventricular ejection fraction at rest in coronary artery disease

artículo científico publicado en 1994

From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes

artículo científico publicado en 2003

Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial).

artículo científico publicado en 2016

Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).

artículo científico publicado en 2013

Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

artículo científico publicado en 2015

Guideline adjudicated fibrinolytic failure: incidence, findings, and management in a contemporary clinical trial

artículo científico publicado en 2007

Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Corona

artículo científico publicado en 2016

Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes

artículo científico publicado en 2013

Heparin in Acute Coronary Disease — Requiem for a Heavyweight? ⬇️

artículo científico publicado el 14 de agosto de 1997

High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction

artículo científico publicado en 2015

Higher T-Wave Amplitude Associated With Better Prognosis in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction (a GUSTO-I Substudy) 11This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massach

scientific article published on 01 May 1998

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil

artículo científico publicado en 2011

Hospital variation in treatment and outcomes in acute coronary syndromes: Insights from the Alberta Contemporary Acute Coronary Syndrome Patients Invasive Treatment Strategies (COAPT) study.

artículo científico publicado en 2017

Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial

artículo científico

How does intermittent pacing modify the response to rapid ventricular pacing in experimental heart failure?

artículo científico publicado en 1995

How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts

artículo científico publicado en 2005

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin

artículo científico publicado en 2017

Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF

artículo científico publicado en 2014

Identifying Low-risk Patients for Early Discharge From Emergency Department Without Using Subjective Descriptions of Chest Pain: Insights From Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT) 3 and 4 Trials.

artículo científico publicado en 2017

Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel

artículo científico publicado en 2016

Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome

artículo científico publicado en 2014

Impact of Sex on Long-term Mortality From Acute Myocardial Infarction vs Unstable Angina

article

Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study

artículo científico publicado en 2012

Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged

artículo científico publicado en 2015

Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes.

artículo científico publicado en 2003

Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial

artículo científico publicado en 2014

Impact of specialist follow-up in outpatients with congestive heart failure

artículo científico publicado en 2005

Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study Group

artículo científico publicado en 1993

Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials

article by Jeffrey A Bakal et al published 24 January 2012 in Statistical Methods in Medical Research

Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review

artículo científico publicado en 2013

Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction

artículo científico publicado en 2016

Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction

artículo científico publicado en 1994

Incidence and Impact on Outcome of Streptokinase Allergy in the GUSTO-I Trial

artículo científico publicado en 1997

Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.

artículo científico publicado en 2001

Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.

artículo científico publicado en 2009

Incidence of heart failure and mortality after acute coronary syndromes

article

Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non–ST-elevation acute coronary syndromes undergoing diagnostic angiography

article

Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes

artículo científico publicado en 2013

Incorporating patient preferences into clinical trial design: Results of the Opinions of Patients on Treatment Implications of New Studies (OPTIONS) project

article

Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy

artículo científico publicado en 2015

Independent data monitoring committees: preparing a path for the future

artículo científico publicado en 2014

Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?

artículo científico publicado en 2015

Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).

artículo científico

Influence of Patient Goals of Care on Performance Measures in Patients Hospitalized for Heart Failure: An Analysis of the Enhanced Feedback For Effective Cardiac Treatment (EFFECT) Registry.

artículo científico publicado en 2015

Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

artículo científico

Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure

artículo científico publicado en 1986

Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy

artículo científico publicado en 2007

Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.

artículo científico publicado en 2004

Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?

artículo científico publicado en 2007

Insights into the contemporary epidemiology and outpatient management of congestive heart failure

artículo científico publicado en 1999

Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial

artículo científico publicado en 2016

Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library

artículo científico publicado en 2008

Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Dec

artículo científico publicado en 2018

International differences in evolution of early discharge after acute myocardial infarction

artículo científico publicado en 2004

International differences in in-hospital revascularization and outcomes following acute myocardial infarction A multilevel analysis of patients in ASSENT-2

article

International variation in and factors associated with hospital readmission after myocardial infarction

artículo científico publicado en 2012

International variation in invasive care of the elderly with acute coronary syndromes.

artículo científico publicado en 2006

International variation in the use of evidence-based medicines for acute coronary syndromes

artículo científico publicado en 2003

Interprovincial Differences in Canadian Coronary Care Unit Resource Use and Outcomes.

artículo científico publicado en 2016

Intracoronary streptokinase in acute myocardial infarction

artículo científico publicado en 2010

Intraluminal Thrombus in Facilitated Versus Primary Percutaneous Coronary Intervention

artículo científico publicado en 2011

Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.

artículo científico publicado en 2018

Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction

artículo científico publicado en 2010

It's a matter of time: contemporary pre-hospital management of acute ST elevation myocardial infarction

artículo científico publicado en 2005

Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy

artículo científico

Large streamlined trials in cardiovascular disease

artículo científico publicado en 2014

Late assessment of thrombolytic efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction

article

Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.

artículo científico publicado en 2013

Lessons learned from a clinical trial

artículo científico publicado en 2004

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2016

Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.

artículo científico publicado en 2015

Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina: One-Year Survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial

artículo científico publicado en 2003

Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.

artículo científico publicado en 2004

Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY mana

artículo científico publicado en 2015

Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.

artículo científico publicado en 2015

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

article

MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury

artículo científico publicado en 2005

Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization

artículo científico

Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis

artículo científico publicado en 1990

Management of unstable angina: tailoring therapeutic elements and intensity to risk profile

Measurement of angiotensin II: Use of two injectors to minimize HPLC shadowing

scientific article published on 01 January 1994

Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).

artículo científico publicado en 2010

Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF.

artículo científico publicado en 2013

Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes

artículo científico publicado en 2015

Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia

article

Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy

artículo científico publicado en 2013

Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization

artículo científico publicado en 2002

Mode of hospital presentation in patients with non-ST-elevation myocardial infarction: implications for strategic management

artículo científico publicado en 2011

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

artículo científico publicado en 2002

Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial

artículo científico

Moving proximally through the intersection between the process and the content of care in ST-elevation myocardial infarctionThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the Europe

scientific article published on 15 August 2005

N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes: Vericiguat Heart Failure With Reduced Ejection Fraction Study

scientific article published on 07 October 2020

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

artículo científico publicado en 2003

Navigating Choices Among a Sea of Comorbidities ∗

artículo científico publicado en 2017

Nebivolol in older adults with heart failure: reduced rates for seniors?

artículo científico publicado en 2009

Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials

artículo científico publicado en 2016

Nitroglycerin ointment in acute myocardial infarction

artículo científico publicado el 1 de octubre de 1976

No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial

artículo científico publicado en 2007

Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

artículo científico publicado en 2010

Noninvasive assessment of speed and stability of infarct-related artery reperfusion: Results of the GUSTO ST segment monitoring study

article

Noninvasive, medical management for non-ST-elevation acute coronary syndromes

artículo científico publicado en 2008

Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes

artículo científico publicado en 2021

Novel vascular effects of isoprenaline following pacing-induced heart failure in the dog.

artículo científico publicado en 1991

On-line microcomputer system for analysis of precordial maps

artículo científico publicado en 1982

One question, two answers: do the two most commonly used methods of sampling describe the length of the prospective wait for admission to hospital?

artículo científico

One-year follow-up of the ASSENT-2 trial: A double-blind, randomized comparison of single-bolus tenecteplase and front-loaded alteplase in 16,949 patients with ST-elevation acute myocardial infarction

artículo científico publicado en 2003

Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial

article

Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial

artículo científico publicado en 2004

Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab

artículo científico publicado en 2003

Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b

artículo científico publicado en 2016

Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).

artículo científico publicado en 2014

Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes

artículo científico publicado en 2006

Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial

artículo científico publicado en 2002

Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials

artículo científico publicado en 2004

PCI at non-PCI centres: immediate or rescue?

scientific article published in The Lancet

Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure.

artículo científico publicado en 1999

Pathophysiology and prognostic significance of holter-detected ST segment depression after myocardial infarction

scientific article published on 01 November 1992

Patient and informal caregivers’ knowledge of heart failure: necessary but insufficient for effective self-care

artículo científico publicado en 2009

Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes

artículo científico publicado en 2005

Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction.

artículo científico publicado en 2012

Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience

artículo científico publicado en 2002

Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial

artículo científico publicado en 2010

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial

artículo científico

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

artículo científico publicado en 2003

Physical Activity and Mortality in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2017

Physical activity in patients with stable coronary heart disease: an international perspective

artículo científico publicado en 2013

Physiologic straws in the wind: in which direction do they bend?

artículo científico publicado en 2007

Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment

artículo científico publicado en 2010

Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure

artículo científico publicado en 1996

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy

artículo científico publicado en 2012

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

scientific article published in The Lancet

Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI

scientific article published on 01 July 2020

Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes trial.

artículo científico publicado en 1998

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

artículo científico publicado en 2012

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial

artículo científico publicado en 2013

Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer

artículo científico publicado en 2016

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy

artículo científico publicado en 2010

Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.

artículo científico publicado en 2002

Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes

artículo científico

Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention

artículo científico publicado en 2010

Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction

artículo científico publicado en 2012

Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.

artículo científico publicado en 2000

Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models

artículo científico

Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes

scientific article published on 08 November 2006

Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North America

artículo científico publicado en 2003

Prior Coronary Artery Bypass Graft Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

article

Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey

article

Prognostic Implications of Changes in Amino-Terminal Pro-B-Type Natriuretic Peptide in Acute Decompensated Heart Failure: Insights From ASCEND-HF

scientific article published on 4 April 2019

Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure

artículo científico publicado en 2015

Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.

artículo científico publicado en 2018

Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial

artículo científico publicado en 2005

Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

artículo científico publicado en 2014

Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study

artículo científico publicado en 2013

Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction

artículo científico publicado en 2014

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy

artículo científico publicado en 2013

Prognostic significance of elevated troponin I after percutaneous coronary intervention

artículo científico publicado en 2002

Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial).

artículo científico publicado en 2005

Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network

artículo científico publicado en 2001

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

artículo científico publicado en 2007

Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes

artículo científico publicado en 2003

Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria

artículo científico publicado en 2006

Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 (PROACT-3).

artículo científico publicado en 2014

Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT-4).

artículo científico publicado en 2015

Public sensationalism and clinical trials: how to address the challenges of science?

artículo científico publicado en 2010

Quantitative ST-depression in acute coronary syndromes: the PLATO electrocardiographic substudy

artículo científico publicado en 2013

Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy

artículo científico publicado en 2011

Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy

artículo científico publicado en 2013

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coron

artículo científico publicado en 1998

Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

artículo científico publicado en 2008

Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

artículo científico publicado en 2003

Randomized trial of prostacyclin infusion in acute myocardial infarction

artículo científico publicado en 1988

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial

artículo científico publicado en 2009

Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF

scientific article published on 17 July 2018

Rationale and Design of the VITALITY-HFpEF Trial

scientific article published on 01 May 2019

Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes

artículo científico publicado en 1998

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

artículo científico publicado en 2008

Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes

artículo científico publicado en 2001

Rear-View Mirror Observations on Bleeding in Acute Coronary Syndromes⁎⁎Editorials published in the JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Intervention

artículo científico publicado en 2010

Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial

artículo científico publicado en 2015

Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER.

artículo científico publicado en 2014

Refining clinical trial composite outcomes: an application to the Assessment of the Safety and Efficacy of a New Thrombolytic-3 (ASSENT-3) trial

artículo científico publicado en 2011

Regional Variation across the United States in the Management of Acute Myocardial Infarction

article

Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators.

artículo científico publicado en 1998

Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial

artículo científico publicado en 2012

Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)

scientific article published on 03 August 2018

Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris

artículo científico publicado en 1990

Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (ST

artículo científico publicado en 2016

Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points

article

Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine inva

artículo científico publicado en 2014

Relationship of Incorrect Dosing of Fibrinolytic Therapy and Clinical Outcomes

artículo científico publicado en 2005

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes

artículo científico publicado en 2004

Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk

Remodeling and reparation of the cardiovascular system

artículo científico publicado el 1 de julio de 1992

Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes

artículo científico publicado en 2015

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study

artículo científico publicado en 2004

Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI Angiographic Study

scientific article published on 27 March 2008

Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysis

artículo científico publicado en 2009

Reperfusion in waiting: What queue should we join?

artículo científico publicado en 2002

Reproducibility of the pharmacokinetic-hemodynamic response to nitroglycerin in the dog: A model for studying the effects of chronic treatment

article

Requiem for the sounds of silence

artículo científico publicado en 2008

Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction

artículo científico publicado en 2009

Resource Use in the Last 6 Months of Life Among Patients With Heart Failure in Canada

article

Resource use and costs of treatment with anticoagulation and antiplatelet agents: results of the WATCH trial economic evaluation

artículo científico publicado en 2009

Response of atrial natriuretic factor to postural change in patients with heart failure versus subject with normal hemodynamics

article

Response to Letter Regarding Article, “Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial”

Response to letter "associations of inflammatory biomarkers to body mass index among patients with acute coronary syndrome".

artículo científico publicado en 2013

Right direction—moving proximally in timing of STEMI care

artículo científico publicado en 2014

Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction Dichotomous response as a function of age in the GUSTO V trial

article

Risk stratification in non-ST elevation acute coronary syndromes: searching for the right formula

article

Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries

artículo científico publicado en 1999

Road mapping ATLAS ACS 2: are we there yet?

scientific article published on 31 January 2012

Role of resting thallium201 perfusion in predicting coronary anatomy, left ventricular wall motion, and hospital outcome in unstable angina pectoris

artículo científico publicado en 1989

Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment El

artículo científico publicado en 2013

Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials

artículo científico publicado en 2014

Ruminating on OAT: is the case closed?

scientific article published on 13 February 2007

ST Elevation Acute Coronary Syndromes in PLATO

article

ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3.

artículo científico publicado en 2008

ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction

artículo científico publicado en 2003

ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome

artículo científico publicado en 1989

ST-Segment Resolution and Outcome in Myocardial Infarction

artículo científico publicado en 2010

ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy

artículo científico

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

artículo científico publicado en 2008

ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up

artículo científico

ST2 and mortality in non-ST-segment elevation acute coronary syndrome

artículo científico publicado en 2010

STREAM characterisation correction

artículo científico publicado en 2017

Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes

artículo científico publicado en 2002

Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function

artículo científico publicado en 2011

Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Ear

artículo científico publicado en 2009

Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial

artículo científico publicado en 2001

Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysis

artículo científico publicado en 2018

Searching for Adherence: Can We Fulfill the Promise of Evidence-Based Medicines?

artículo científico publicado en 2016

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

artículo científico publicado en 2017

Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2017

Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes

artículo científico publicado en 2012

Serum Magnesium and Potassium in Acute Myocardial Infarction

artículo científico publicado en 1987

Sex differences in mortality following acute coronary syndromes

artículo científico publicado en 2009

Sex differences in patients seeking medical attention for prodromal symptoms before an acute coronary event

artículo científico publicado en 2008

Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years

artículo científico publicado en 2015

Sharing Data from Cardiovascular Clinical Trials--A Proposal

artículo científico publicado en 2016

Short- and Long-Term Outcomes of Patients With Electrocardiographic Left Ventricular Hypertrophy After Fibrinolysis for Acute Myocardial Infarction

artículo científico publicado en 2005

Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation

artículo científico publicado en 2008

Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers

artículo científico publicado en 2006

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

artículo científico publicado en 1999

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.

artículo científico publicado en 2016

Specific and non-specific measurements of tissue angiotensin II cascade members

artículo científico publicado en 2001

Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial

artículo científico publicado en 2016

Spotting the pantomime villain: do the usual approaches correctly indicate when waiting times got shorter?

artículo científico publicado en 2010

Stereoselective synthesis of (8R,8aS)-8-methylhexahydroindolizin-5-one

Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

artículo científico publicado en 2011

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial

artículo científico publicado en 2018

Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes

artículo científico

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.

artículo científico publicado en 2017

Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes

artículo científico publicado en 2002

Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial

artículo científico publicado en 2003

Synthesis of the putative structures of homopumiliotoxins 235C and 233F

Tandem intramolecular Michael addition and 1,3-dipolar cycloaddition reactions of oximes; versatile new carbon–carbon bond forming methodology

article

Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome

artículo científico

Temporal and Provincial Variation in Ambulance Use Among Patients Who Present to Acute Care Hospitals With ST-Elevation Myocardial Infarction.

artículo científico publicado en 2016

Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction

artículo científico publicado en 2016

Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction

artículo científico publicado en 2011

Testosterone supplementation in heart failure: a meta-analysis

artículo científico publicado en 2012

Testosterone therapy in women with heart failure "why can't a woman be more like a man?".

artículo científico publicado en 2010

The 49th parallel: How much latitude?

scientific article published on 01 November 1995

The Canadian Academy of Health Sciences: coming of age at the right time

artículo científico publicado en 2008

The Choice Is Reperfusion Therapy

artículo científico publicado en 2016

The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients

article

The Effects of Climate Change on Cardiac Health

artículo científico publicado en 2015

The Power of More Than One

artículo científico publicado en 2013

The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study

artículo científico publicado en 2010

The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics

artículo científico publicado en 2004

The association between meteorological events and acute heart failure: new insights from ASCEND-HF.

artículo científico publicado en 2014

The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF

artículo científico publicado en 2020

The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF

artículo científico publicado en 2015

The ebb and flow of the NHS waiting list: how do recruitment and admission affect event-based measures of the length of 'time-to-admission'?

artículo científico

The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events

artículo científico publicado en 2002

The forgotten lead: does aVR ST-deviation add insight into the outcomes of ST-elevation myocardial infarction patients?

artículo científico publicado en 2013

The future of cardiovascular clinical research in North America and beyond-addressing challenges and leveraging opportunities through unique academic and grassroots collaborations

artículo científico

The future of clinical trials in secondary prevention after acute coronary syndromes ⬇️

artículo científico publicado el 29 de octubre de 2010

The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction

artículo científico publicado en 2006

The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2⋆

artículo científico publicado en 2003

The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention

artículo científico publicado en 2009

The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST

article

The long-term effects of dietary sodium restriction on clinical outcomes in patients with heart failure. The SODIUM-HF (Study of Dietary Intervention Under 100 mmol in Heart Failure): a pilot study.

artículo científico publicado en 2014

The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directions

artículo científico

The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes

artículo científico publicado en 2002

The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: The GUSTO-IIb ECG Core Laboratory experience

The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial

article

The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial

artículo científico

The relationship between meteorological conditions and index acute coronary events in a global clinical trial

artículo científico publicado en 2013

The spectrum of unstable angina: Prognostic role of serum creatine kinase determination

scientific article published on 01 June 1982

The typing of fetal antigen 2 in human amniotic fluid

artículo científico publicado en 1995

The use of beta-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes

artículo científico publicado en 2004

Third Universal Definition of Myocardial Infarction

artículo científico publicado en 2012

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

artículo científico publicado en 2011

Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators.

artículo científico publicado en 1996

Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial

artículo científico publicado en 2005

Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial

artículo científico

Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making

scientific article published on 01 January 2003

Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials

artículo científico publicado en 2007

Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction

artículo científico publicado en 1989

To transfer or not to transfer: acute myocardial infarction reperfusion

Tolerance to organic nitrates: clinical and experimental perspectives

artículo científico publicado en 1983

Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)

artículo científico publicado en 2016

Towards a new order in cardiovascular medicine: re-engineering through global collaboration

article

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

artículo científico publicado en 2017

Transatlantic Comparison of ST-Segment Elevation Myocardial Infarction Guidelines: Insights From the United States and Europe

artículo científico

Transfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights

artículo científico publicado en 2012

Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

artículo científico publicado en 2009

Transition From Meeting Abstract to Full-length Journal Article for Randomized Controlled Trials

artículo científico publicado en 2006

Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials

artículo científico publicado en 2016

Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years

artículo científico publicado en 2012

Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

artículo científico publicado en 2012

Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients

artículo científico publicado en 2003

Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial

artículo científico publicado en 2003

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

artículo científico publicado en 2003

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy

artículo científico publicado en 2006

Two hard lessons ⬇️

artículo científico publicado el 26 de abril de 2003

Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

artículo científico publicado en 2010

Universal definition of myocardial infarction

artículo científico publicado en 2007

Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials

artículo científico publicado en 2006

Upstream Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Treatment in Patients With Acute Coronary Syndrome

article

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials

artículo científico publicado en 2011

Use of electrocardiogram indices of myocardial ischemia for risk stratification and decision making of reperfusion strategies

artículo científico publicado en 2014

Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials

artículo científico publicado en 2007

Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial

artículo científico publicado en 2010

Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program

artículo científico

Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial).

artículo científico publicado en 2000

Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial

artículo científico publicado en 2016

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

artículo científico publicado en 2014

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).

artículo científico publicado en 2005

Usefulness of exercise electrocardiography and thallium scintigraphy in unstable angina pectoris in predicting the extent and severity of coronary artery disease

scientific article published on 01 December 1988

Usefulness of ischemic response to mental stress in predicting silent myocardial ischemia during ambulatory monitoring

artículo científico publicado en 1995

Usefulness of spironolactone in a specialized heart failure clinic

artículo científico publicado en 2004

Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

artículo científico publicado en 2016

Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.

artículo científico publicado en 2008

Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial

artículo científico publicado en 2012

Variations in pre-hospital fibrinolysis process of care: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic 3 Plus international acute myocardial infarction pre-hospital care survey

artículo científico publicado en 2004

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

scientific article published on 28 March 2020

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

artículo científico publicado en 2013

Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).

artículo científico publicado en 2014

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial

artículo científico publicado en 2014

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial.

artículo científico publicado en 2014

Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes

artículo científico publicado en 2010

What do we know? Limitations of the two methods most commonly used to estimate the length of the prospective wait

artículo científico publicado en 2009

What is the frequency and functional and clinical significance of complex lesions in non–infarct-related arteries after fibrinolysis for acute ST-elevation myocardial infarction?

artículo científico publicado en 2006

Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome

artículo científico publicado en 2017

Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF)

artículo científico publicado en 2015

Lista de obras de Paul W. Armstrong

1-Year Survival in a Randomized Trial of Facilitated Reperfusion

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in coll

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial

A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.

A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications

A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study

A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes

A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy

A marriage of enhancement: fibrinolysis and conjunctive therapy

A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

A new synthetic approach to 2,3-dideoxy-2-fluoro-β-d-threo-pentofuranose, the fluorofuranose unit of the anti-HIV-active nucleoside, β-FddA

A novel enoxaparin regime for ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a WEST sub-study

A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes

A tale of two countries: Insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes.

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial.

Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy

Aborted myocardial infarction: a new target for reperfusion therapy

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST–elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy11Guest Editor for this manuscript

Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial

Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Ger

Acute heart failure in the emergency department: Short and long-term outcomes of elderly patients with heart failure

Acute heart failure: perspectives from a randomized trial and a simultaneous registry

Advancing interdisciplinary health research: a synergism not to be denied

Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy

Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.

Age and Outcomes in ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial

Aggressive clinical pattern of angina at restenosis following coronary angioplasty in unstable angina

Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial

Aldosterone Antagonists — Last Man Standing? ⬇️

Alignment of site versus adjudication committee-based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial

Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure

Ameliorating reperfusion injury in STEMI: dead or alive?

An assessment of ST-segment measurement variability between two core electrocardiogram laboratories

An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry

Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

Angiographic morphology in unstable angina pectoris

Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial).

Anticoagulant therapy in unstable angina.

Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.

Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial

Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial

Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction

Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction

Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis

Arrival by ambulance in acute heart failure: insights into the mode of presentation from Acute Studies of Nesiritide in Decompensated Heart Failure (ASCEND-HF).

Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome

Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure

Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation

Assessing risk in FRISC

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous corona

Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow

Assessment of ventricular function in coronary artery disease by means of atrial pacing and exercise

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial

Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial

Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

Association of global weather changes with acute coronary syndromes: gaining insights from clinical trials data

Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes

Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis

Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS

Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience

Balancing the cyclooxygenase portfolio

Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sex.

Baseline Q waves as a prognostic modulator in patients with ST-segment elevation: insights from the PLATO trial

Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival study

Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial

Benefit of Facilitated Percutaneous Coronary Intervention in High-Risk ST-Segment Elevation Myocardial Infarction Patients Presenting to Nonpercutaneous Coronary Intervention Hospitals

Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?

Better Outcomes for Patients Treated at Hospitals That Participate in Clinical Trials

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.